Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomics of COVID-19 Vaccine-induced Adverse Events (Guillain-Barré Syndrome [GBS], Vaccine-induced Immune Thrombotic Thrombocytopenia [VITT]/Thrombosis With Thrombocytopenia Syndrome [TTS], and Myocarditis/Pericarditis)

NCT05212792 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT05212792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05212792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomics of COVID-19 Vaccine-induced Adverse Events (Guillain-Barré Syndrome [GBS], Vaccine-induced Immune Thrombotic Thrombocytopenia [VITT]/Thrombosis With Thrombocytopenia Syndrome [TTS], and Myocarditis/Pericarditis)
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Recruiting
Start date
June 24, 2022
Completion date
December 31, 2026
Enrollment
6,325 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaccine adverse reaction